{
    "Trade/Device Name(s)": [
        "Access 25(OH) Vitamin D Total"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K223503",
    "Predicate Device Reference 510(k) Number(s)": [
        "K142373"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MRG"
    ],
    "Summary Letter Date": "January 19, 2023",
    "Summary Letter Received Date": "November 22, 2022",
    "Submission Date": "November 21, 2022",
    "Regulation Number(s)": [
        "21 CFR 862.1825"
    ],
    "Regulation Name(s)": [
        "Vitamin D test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "25-hydroxyvitamin D",
        "25(OH) vitamin D"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "DxI 9000 Access Immunoassay Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Competitive immunoassay"
    ],
    "Methodologies": [
        "Automated immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Beckman Coulter Access 25(OH) Vitamin D Total chemiluminescent immunoassay for quantitative determination of vitamin D on the DxI 9000 analyzer",
    "Indications for Use Summary": "Quantitative determination of total 25-hydroxyvitamin D in human serum and plasma as an aid in the assessment of vitamin D sufficiency",
    "fda_folder": "Clinical Chemistry"
}